Cuu Long Pharmaceutical receives investment registration for EU-GMP standard pharmaceutical factory project
On November 22, 2022, Cuu Long Pharmaceutical Joint Stock Company was awarded the Decision and Investment Registration Certificate by the Management Board of Long An Economic Zone for the Pharmaceutical Factory Project according to EU-GMP standards.
This is one of 12 typical projects of Long An province.
The EU-GMP standard pharmaceutical factory project of Cuu Long Pharmaceutical has a scale of 50,000 m2, total investment capital of VND 1,035 billion, built at Lot G-1, N2 road, Huu Thanh Industrial Park, Huu commune Thanh, Duc Hoa district, Long An province.
The factory’s production capacity of drugs and pharmaceuticals reaches 1.6 billion products/year, medical supplies such as syringes, needles, infusion lines, blood sample tubes, intravenous needles … reach 360 million production units. product/year.
In the current trend of global integration in the pharmaceutical field, the Good Manufacturing Practices – GMP (Good Manufacturing Practices – European Union) standard is one of the highest standards of the pharmaceutical factory in the world.
This is a set of principles and standards developed and issued by the European Medicines Agency, to control activities or problems occurring at pharmaceutical manufacturing facilities, producing drugs with high quality, ensuring the health of consumers.
Source: Investment newspaper